Can PBMs Save China's Health Care From Running Out Of Money?
Executive Summary
A zeal to cut cost while maintaining care quality is not new to China, but Beijing has a desire to embrace latest technology to its benefits. Pharmacy benefit manager players from the US and Canada are now leaping into the fray with varying degrees of success.
You may also be interested in...
Can Alibaba Use Artificial Intelligence To Solve China Health Issues?
When China’s e-commerce giant Alibaba flexes its muscles, this time in personalized healthcare using artificial intelligence, everyone takes note.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Chinese Language Podcast: BIOSECURE Act, US PD-1 Approval, ADC Updates
Guest speaker and lawyer Kevin Duan joins Brian Yang and Dexter Yan to discuss the planned US BIOSECURE Act, the US approval of BeiGene's anti-PD-1 drug and the latest antibody-drug conjugates in development at Chinese pharma firms.